title: Fondaparinux reversal with activated prothrombin complex concentrate in anesthetised bleeding rats.
authors.forename: Gilles
authors.initials: G
authors.lastname: Corbonnois
authors.forename: Michèle
authors.initials: M
authors.lastname: Martin
authors.forename: Marie
authors.initials: M
authors.lastname: Hacquard
authors.forename: Bruno
authors.initials: B
authors.lastname: Levy
authors.forename: Paul Michel
authors.initials: PM
authors.lastname: Mertes
authors.forename: Thomas
authors.initials: T
authors.lastname: Lecompte
authors.forename: Gérard
authors.initials: G
authors.lastname: Audibert
mesh_terms: D000758:Anesthesia / Q000379:methods; D000818:Animals; D000925:Anticoagulants / Q000037:antagonists & inhibitors*; D001158:Arteries / Q000473:pathology; D001794:Blood Pressure; D015942:Factor VIIa / Q000627:therapeutic use*; D000077425:Fondaparinux; D006470:Hemorrhage / Q000188:drug therapy*; D006487:Hemostasis; D008297:Male; D011134:Polysaccharides / Q000037:antagonists & inhibitors*; D011516:Prothrombin / Q000378:metabolism / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000627:therapeutic use; D013917:Thrombin / Q000378:metabolism; D013997:Time Factors
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D011994:Recombinant Proteins; D011516:Prothrombin; C103587:recombinant FVIIa; D015942:Factor VIIa; D013917:Thrombin; D000077425:Fondaparinux